Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 366 (LINC00366) is a human long intergenic non-coding RNA (lincRNA) that does not encode a protein. Members of the lincRNA family are primarily transcribed from regions of the genome that do not overlap known coding genes, and are longer than 200 nucleotides[3][5]. LINC00366 itself has not been characterized functionally in the literature as of the latest search. More broadly, lincRNAs are implicated in diverse regulatory roles such as chromatin remodeling and gene expression modulation, but the specific biological functions, regulatory roles, or disease associations of LINC00366 remain currently uncharacterized, with no evidence to support its use as a therapeutic target or biomarker[1][3][5].
Not applicable (no drugs known to target LINC00366)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 366 (LINC00366).